According to a study published in the Canadian Journal of Infectious Disease and Medical Microbiology in 2021, more than 1.3 million cases of needlestick injuries (NSI) among health care workers (HCWs) are reported every year in the US and Europe. NSIs are known to occur frequently in healthcare settings while using injections and can lead to transmission of various blood borne pathogen. In fact, as per the estimates provided by the Centers for Disease Control and Prevention (CDC), HCWs are at an increased risk of exposure to harmful pathogens, such as human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus, due to needlesticks. Some of the common factors that are believed to be the cause for high number of NSIs include inessential use of sharp devices, inadequacy of personal protective equipment, lack of training, and inappropriate disposal of sharp devices and needles. In order to reduce the number of such cases, several initiatives have been undertaken to ensure safety of HCWs and patients, which include the launch of 2010 EU directive initiative on sharps injury prevention by the European Union and development of smart needles and advanced injection devices. Since the use of needles is unavoidable in healthcare, device developers have come up with highly advanced product designs and safety measurements to limit the risk posed by sharp needles. These safety injection devices have several advantages, including needle shielding and automatic retraction of needles into the syringe barrel when the plunger is released, and easy disposal of safety needles.
Given the various benefits of needlestick safety injection devices, several companies have developed and launched their proprietary smart devices that are capable of preventing injuries caused by needlesticks along with reducing the transmission of infectious diseases. In addition, in order to expand the reach of their devices and enhance their product portfolios, players in this domain are actively collaborating with other stakeholders. Moreover, the stakeholders have undertaken several initiatives to augment their intellectual portfolio with an intention to incorporate advanced features to their products. Driven by the growing demand for safe and efficient drug delivery systems and ongoing efforts by the players to integrate sophisticated features in the product design and technology, the needlestick safety injection devices market is likely to witness noteworthy growth over the coming years.
Scope of the Report
The “Needlestick Safety Injection Devices Market by Type of Device (Needles, Syringes, and Other types of devices), Purpose of Device (Needle Shielding, Protection against Injuries, and Enabling ease of Needle Insertion / Retraction), Usability (Non-Reusable and Reusable), Company Size (Very Large, Large, Mid-sized, Small and Very Small) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the needlestick safety injection devices (either commercialized or under development) in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
- A detailed assessment of the market landscape of needlestick safety injection devices based on several relevant parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion/retraction, protection against injuries, and needle shielding), usability (non-reusable and reusable), mode of sterilization (ethylene oxide, gamma rays, steam and other methods) and packaging format (box, tub, and other packaging formats). In addition, it features analysis of the companies engaged in the development/deployment of needlestick safety injection devices, along with information on their year of establishment, company size, location of headquarters, and leading players (in terms of number of needlestick safety injection devices developed).
- An in-depth key insights analysis, highlighting the contemporary market trends using impactful schematic representations, including a tree map representation, based on type of device (needle, syringe, and other types of devices) and company size, a waffle chart representation, based on purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding) and company size, a 4D bubble analysis, which compares the capabilities of leading players engaged in the development / deployment of needlestick safety injection devices, based on various parameters, such as type of device (needle, syringe, and other types of devices), purpose of device (enabling ease of needle insertion / retraction, protection against injuries, and needle shielding), company size and location of headquarters (region-wise), a world map representation, highlighting the regional distribution of leading players engaged in the development / deployment of needlestick safety injection devices and a grid representation, based on type of device, purpose of device and usability.
- A detailed product competitiveness analysis of needlestick safety injection devices, based on supplier power (based on the experience of the developer in this industry) and key specifications of products, including purpose of device (enabling ease of needle insertion/retraction, protection against injuries and needle shielding), usability (non-reusable and reusable), mode of sterilization (gamma rays, ethylene oxide, steam, and other methods).
- An in-depth analysis of various initiatives undertaken in this domain, during the period 2016-2022, wherein companies have entered into partnerships with other stakeholders related to needlestick safety injection devices and the related recent events (conferences/seminars/webinars/workshops) organized by several stakeholders, across the globe. In addition, it provides information on the funding activity in this domain, highlighting the involvement of venture capitalists and funding schemes of various public and private organizations/funds that have allowed start-ups / small companies to expand their capabilities.
- An analysis of the patents filed/granted for needlestick safety injection devices, since 2018, taking into consideration several relevant parameters, such as type of patent, publication year, application year, issuing authority, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus areas, type of organization, leading industry and non-industry players (on the basis of number of patents filed/granted) and individual patent assignees (in terms of size of intellectual property portfolio), patent benchmarking, patent characteristics and age of patents. In addition, the chapter also includes an insightful patent valuation analysis and leading patents by number of citations.
- Elaborate profiles of key players engaged in the development of needlestick safety injection devices. Each profile features a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook. Additionally, it provides a detailed scoring matrix of leading players profiled in this chapter (based on the recent initiatives).
- A Bowman’s strategy clock framework to understand the pricing strategy of the needlestick safety injection devices developed by the company along with its competitive position in the marketplace. In addition, it presents the equation devised to calculate the likely price of the needlestick safety injection devices based upon their features.
One of the key objectives of the report was to evaluate the existing market size, primary growth factors and future opportunity within the needlestick safety injection devices market in the mid to long term. Our year-wise projections of the current and future opportunity within the needlestick safety injection devices market have further been segmented across types of devices (needles, syringes, and other types of devices), purposes of devices (enabling ease of needle insertion/retraction, protection against injuries, and needle shielding), usability (reusable and non-reusable), company size of developers (very small, small, mid-sized, large and very large) and geographical regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Key Questions Answered
- Who are the leading players engaged in the development of needlestick safety injection devices?
- Which are the popular types of safety injection devices available in the market?
- What are the key challenges associated with the development of needlestick safety injection devices?
- Which type of partnership models are commonly being adopted by industry stakeholders?
- How has the intellectual property landscape of needlestick safety injection devices developers evolved over the years?
- What factors are likely to influence the evolution of this market?
- How is the current and future market opportunity likely to be distributed across key market segments?
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
Companies Mentioned
- angiplast
- Alder Hey Children's NHS Foundation Trust
- Autosafe-Reflex
- B. Braun
- BD
- Ben Franklin Technology Partners of Northeastern Pennsylvania
- Biocorp
- Biomedical Advanced Research and Development Authority (BARDA) (US Department of Health and Human Services)
- Biotechnology Industry Research Assistance Council (BIRAC)
- Cardinal Health
- C-Major Medical
- Corning
- CPhI North America
- Credence MedSystems
- CVS Health
- Demophorius Healthcare
- Devex
- DMC MEDICAL
- DuoProSS Meditech
- EREF Education Program
- European Commission
- Express Pharma
- FourKites
- Gerresheimer
- Greiner
- HexArmor
- Hindustan Syringes and Medical Device (HMD)
- HTL-STREFA
- ICU Medical
- Immersify Education
- Investindustrial
- ISO-MED
- ITL BioMedical
- Kansas Department of Commerce
- KB Medical Group
- Kentucky Chamber
- Kerma Medical Products
- Kinaxis
- Kingfriend
- Kinled Holding
- K-One Technology
- Lepu Medical Technology
- Love Lifesciences
- Lubrizol
- MedicalChain International
- Medicina
- Medi-Globe
- Medi-Hut
- MediPurpose
- Medline
- MedPro Safety Products
- MHC Medical Products
- Michigan Strategic Fund (MSF)
- Midven
- Molex Ventures
- NeedleSmart
- Nemera
- Nipro Europe Group Companies
- Noble
- Novartis Pharma
- Novo Nordisk
- Numedico Technologies
- Ohio Pharmacists Association
- Owen Mumford
- Parenteral Drug Association
- Perouse Medical (Acquired by Vygon)
- Pharmapack Symposium
- Phillips-Medisize
- Pierrel
- PragmatIC
- Prism Medical & Design
- Protectus Medical Devices
- Q STAT
- RAUMEDIC
- Retractable Technologies
- Revolutions Medical
- Right Way Medical
- SCHOTT
- Schreiner Group
- Schreiner MediPharm
- Septodont
- SHANGHAI BERPU MEDICAL
- Smiths Medical
- Sol-Millennium
- Star Syringe
- Tangent Medical Technologies
- Terumo Medical
- Texas Pharmacy Association
- BSI
- The International Medical Community
- Tip-Top
- Troge Medical
- UltiMed
- Upper Midwest Agricultural Safety and Health Center (UMASH)
- U.S. Army Contracting Command
- US Department of Defense
- US Department of Health and Human Services
- UVEX
- Venus
- Vogt Medical
- West Pharmaceutical Services
Methodology
LOADING...